Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
69.03
+1.29 (1.90%)
At close: Apr 24, 2026, 4:00 PM EDT
69.00
-0.03 (-0.04%)
After-hours: Apr 24, 2026, 7:43 PM EDT
Oruka Therapeutics Market Cap
Oruka Therapeutics has a market cap or net worth of $3.47 billion as of April 24, 2026. Its market cap has increased by 1,190.79% in one year.
Market Cap
3.47B
Enterprise Value
2.99B
1-Year Change
1,190.79%
Ranking
Category
Stock Price
$69.03
Market Cap Chart
Since August 30, 2024, Oruka Therapeutics's market cap has increased from $849.32M to $3.47B, an increase of 307.98%. That is a compound annual growth rate of 134.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 3.47B | 136.16% |
| Dec 31, 2025 | 1.47B | 116.22% |
| Dec 31, 2024 | 678.62M | -20.10% |
| Aug 30, 2024 | 849.32M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viking Therapeutics | 3.80B |
| ACADIA Pharmaceuticals | 3.74B |
| Travere Therapeutics | 3.74B |
| Tango Therapeutics | 3.72B |
| Telix Pharmaceuticals | 3.61B |
| NewAmsterdam Pharma Company | 3.42B |
| Edgewise Therapeutics | 3.39B |
| Catalyst Pharmaceuticals | 3.34B |